Entecavir is superior to lamivudine for the treatment of HBeAg(+) chronic hepatitis B: results of Phase III study ETV-022 in nucleoside-naive patients

被引：0
|
作者：
Chang, TT
Gish, R
de Man, R
Gadano, A
Sollano, J
Han, KH
Goodman, Z
Zhu, J
Cross, A
DeHertogh, D
Apelian, D
机构：
[1] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
[2] Calif Pacific Med Ctr, San Francisco, CA USA
[3] Erasmus Univ Hosp, Rotterdam, Netherlands
[4] H22 Hosp, Buenos Aires, DF, Argentina
[5] Univ Santo Tomas, Manila, Philippines
[6] Yonsei Univ, Coll Med, Severance Hosp, Seoul, South Korea
[7] Armed Forces Inst Pathol, Washington, DC 20306 USA
[8] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA
来源：
ANTIVIRAL THERAPY | 2004年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：H21 / H22
页数：2
相关论文
共 50 条
  • [41] LONG-TERM ENTECAVIR TREATMENT FOR UP TO 5 YEARS IN ASIANS WITH HBEAG-POSITIVE NUCLEOS(T)IDE NAiVE CHRONIC HEPATITIS B: RESULTS FROM ETV-022 AND-901
    Pan, Calvin
    Tong, Myron J.
    Kowdley, Kris V.
    Hu, Ke-Qin
    Chang, Ting-Tsung
    Lai, Ching-Lung
    Yoon, Seung Kew
    Lee, Samuel S.
    Cohen, David S.
    Tang, Hong
    Tsai, Naoky C. S. C.
    HEPATOLOGY, 2010, 52 (04) : 557A - 557A
  • [42] Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naive Chinese patients with chronic hepatitis B: a randomized, multicenter study
    Yao, Guangbi
    Chen, ChengWei
    Lu, WeiLun
    Ren, Hong
    Tan, DeMing
    Wang, YuMing
    Xu, DaoZheng
    Liu, Jessica
    Xu, Dong
    Llamoso, Cyril
    HEPATOLOGY INTERNATIONAL, 2008, 2 (04) : 486 - 493
  • [43] IMPACT OF ENTECAVIR VERSUS LAMIVUDINE ON HEPATIC COVALENTLY CLOSED-CIRCULAR DNA AND TOTAL HEPATIC HBVDNA IN NUCLEOSIDE-NAIVE HBeAg POSITIVE CHRONIC HEPATITIS B PATIENTS
    Bowden, S.
    Locarnini, S.
    Chang, T. -T.
    Chao, Y. -C.
    Han, K. -H.
    Gish, R. G.
    de Man, R.
    Llamoso, C.
    Tang, H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S308 - S309
  • [44] Efficacy of entecavir monotherapy in nucleoside-naive patients with chronic hepatitis B in a tertiary clinic setting
    Davison, S. A.
    Dobbins, T. A.
    Segaert, N.
    Koorey, D. J.
    Shackel, N. A.
    Bye, W. A.
    Selby, W. S.
    McCaughan, G. W.
    Strasser, S. I.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A282 - A282
  • [45] Efficacy and safety of entecavir compared to lamivudine in nucleoside-naive patients with chronic hepatitis B: a randomized double-blind trial in China
    Yao, Guangbi
    Chen, Chengwei
    Lu, Weilun
    Ren, Hong
    Tan, Deming
    Wang, Yuming
    Xu, Daozheng
    Jiang, Zhengrong
    Liu, Jessica
    Xu, Dong
    MacDonald, Laurie
    HEPATOLOGY INTERNATIONAL, 2007, 1 (03) : 365 - 372
  • [46] Simultaneous Emergence of Entecavir Resistance Mutations in a Nucleoside-Naive Chronic Hepatitis B Patient
    Lee, Hyun Woong
    Kim, Hyung Joon
    Hong, Sun Pyo
    Cha, Bong Ki
    Chang, Hye Young
    Choi, Chang Hwan
    Do, Jae Hyuk
    Kim, Jae Gyu
    Chang, Sae Kyung
    INTERVIROLOGY, 2012, 55 (05) : 380 - 384
  • [47] Impact of Entecavir Versus Lamivudine on Hepatic Covalently Closed-Circular DNA and Total Hepatic HBV DNA in Nucleoside-NaiVE HBeAg Positive Chronic Hepatitis B Patients
    Bowden, Scott
    Locarnini, Stephen
    Chang, Ting-Tsung
    Chao, You-Chen
    Han, Kwang-Hyub
    Gish, Robert G.
    De Man, Robert A.
    Llamoso, Cyril
    Tang, Hong
    GASTROENTEROLOGY, 2013, 144 (05) : S950 - S950
  • [48] Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infection
    Yokosuka, Osamu
    Takaguchi, Koichi
    Fujioka, Shinichi
    Shindo, Michiko
    Chayama, Kazuaki
    Kobashi, Haruhiko
    Hayashi, Norio
    Sato, Chifumi
    Kiyosawa, Kendo
    Tanikawa, Kyuichi
    Ishikawa, Hiroki
    Masaki, Nobuyuki
    Seriu, Taku
    Omata, Masao
    JOURNAL OF HEPATOLOGY, 2010, 52 (06) : 791 - 799
  • [49] ENTECAVIR RESISTANCE IN ENTECAVIR NAIVE LAMIVUDINE TREATED CHRONIC HEPATITIS B PATIENTS
    Sayan, Murat
    Hulagu, Sadettin
    Akhan, Sila Cetin
    Senturk, Omer
    Meric, Meliha
    Cekmen, Mustafa
    MIKROBIYOLOJI BULTENI, 2009, 43 (03): : 425 - 432
  • [50] LONG-TERM ENTECAVIR THERAPY RESULTS IN REVERSAL OF FIBROSIS/CIRRHOSIS AND CONTINUED HISTOLOGIC IMPROVEMENT IN PATIENTS WITH HBEAG(+) AND (-) CHRONIC HEPATITIS B: RESULTS FROM STUDIES ETV-022,-027 AND-901
    Liaw, Yun-Fan
    Chang, Ting-Tsung
    Wu, Shun-Sheng
    Schiff, Eugene R.
    Han, Kwong-Hyub
    Lai, Ching-Lung
    Safadi, Rifoot
    Lee, Samuel S.
    Holota, Waldemar
    Goodman, Zachary D.
    Zhang, Hui
    Hindes, Robert
    Iloeje, Uchenno
    Beebe, Suzanne
    Kreter, Bruce
    HEPATOLOGY, 2008, 48 (04) : 706A - 706A
12345